NAV
$195.79
AUM
$7.9B
Expense Ratio
-
Dividend Yield
0.18%
Beta
0.71
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +15.96% | +16.18% | +15.92% | +52.75% | +15.89% | +3.78% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | GILD | Gilead Sciences Inc | 7.42% |
| 2 | VRTX | Vertex Pharmaceuticals Inc | 7.40% |
| 3 | AMGN | Amgen Inc | 7.13% |
| 4 | REGN | Regeneron Pharmaceuticals Inc | 5.69% |
| 5 | ALNY | Alnylam Pharmaceuticals Inc | 3.61% |
| 6 | ARGX | argenx SE ADR | 3.49% |
| 7 | NTRA | Natera Inc | 2.68% |
| 8 | BIIB | Biogen Inc | 2.61% |
| 9 | RVMD | Revolution Medicines Inc Ordinary Shares | 2.47% |
| 10 | ILMN | Illumina Inc | 2.20% |
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Inception Date: 2001-02-05